The Investor Relations website contains ... Recent Updates. Stock Details · Stock DetailsStock Summary | APVO | NASDAQ GS $0.75+0.0118 (+1.60%) ... E-mail: IR@apvo.
A clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer.
(“Aptevo”) (Nasdaq: APVO), a biotechnology company ... Senior Director, Investor Relations and Corporate Communications. Direct: (206) 859-6616. Email: IR@apvo.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
People also ask
Who is the CEO of APVO?
Where is Aptevo Therapeutics located?
Ms. Taylor leads Finance, Investor Relations, and IT and previously served as Aptevo's Senior Vice President of Finance where she held responsibility for all ...
Mar 5, 2024 · Head, Investor Relations & Corporate Communications Aptevo Therapeutics Email: IR@apvo.com or Millerm@apvo.com. Phone: 206-859-6628. SOURCE ...
Trademarks owned by Aptevo Therapeutics Inc. and its subsidiaries. Where possible, we pursue registered trademarks for our marketed products in significant ...
People also search for